Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
1994 Consensus Conference on Acute GVHD Grading.
1995 • 4,743 citations
Biochemistry and clinical applications of ribavirin
1986 • 255 citations
Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation
1992 • 247 citations
Respiratory Disease Due to Parainfluenza Virus in Adult Bone Marrow Transplant Recipients
1996 • 170 citations
Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial
1997 • 129 citations
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
1997 • 126 citations
The lung as a critical organ in marrow transplantation.
1994 • 112 citations
Parainfluenza Virus Infection Among Adults Hospitalized for Lower Respiratory Tract Infection
1999 • 110 citations
Parainfluenza Virus 3 Infection after Stem Cell Transplant: Relevance to Outcome of Rapid Diagnosis and Ribavirin Treatment
2001 • 109 citations
Outbreak of Pneumonia in a Long‐term Care Facility: Antecedent Human Parainfluenza Virus 1 Infection May Predispose to Bacterial Pneumonia
1998 • 69 citations
Parainfluenza Virus Type 3 Infections in Hematopoetic Stem Cell Transplant Recipients: Response to Ribavirin Therapy
2000 • 61 citations
The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3
1996 • 35 citations
Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3.
1994 • 23 citations